Clinical Practice Points• This case report points out, unusual case of man with testicular
cancer who experienced late relapse in unusual site of metastasis or another sequential …

Simple Summary This study aimed to assess the impact of PET/CT on the management of
patients with germ cell tumors (GCTs) in a real-world setting, specifically in terms of avoiding …

Testicular cancer is the most common solid neoplasm of adult men between the ages of 20
and 40 years. Germ cell tumors account for 95% of all testicular tumors. The assessment of …

Background and objective Serum levels of microRNA-371a-3p (M371) represent a novel
and sensitive biomarker of germ cell tumours (GCTs). This study analysed the utility of M371 …

Standard care for stage I testicular germ cell cancers (seminomatous—STC or non-
seminomatous—NSTC) is orchiectomy followed by active surveillance, 1 or 2 cycles of …

Testicular germ cell tumors are the most common tumors in adolescent and young men.
They are curable malignancies that should be treated with curative intent, minimizing acute …

Germ cell tumor of the testis (GCT) is a curable cancer even when it is widely metastatic;
however, outcomes can differ based on tumor histology. Chemo-resistance in certain …

Background Testicular germ cell tumors (GCTs) are aggressive but highly curable tumors.
To avoid over/undertreatment, reliable clinical staging of retroperitoneal lymph-node …

Purpose In testicular neoplasms, the interrelationship of elevations of the novel serum tumor
marker microRNA-371a-3p (M371) and traditional markers with other clinical features is still …

Background Testicular cancer incidence among adolescents and young adults (AYAs, aged
18-39 years at diagnosis) is increasing worldwide and most patients will survive the initial …